ARTICLE | Clinical News
Vyxeos regulatory update
October 10, 2016 7:00 AM UTC
Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Dublin, Ireland Product: Vyxeos ( CPX-351) Business: Cancer Jazz began submission of a rolling NDA to FDA for Vyxeos to treat acute myelogenous leukemia (AML)....